Literature DB >> 22042095

The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis.

Peng Chen1, Shao-jin Wang, Hong-bo Wang, Peng Ren, Xi-qian Wang, Wen-guang Liu, Wan-li Gu, Dong-qing Li, Ting-guo Zhang, Cheng-jun Zhou.   

Abstract

The aim of this study was to investigate the expression patterns of IGF2 and IMP3 in osteosarcoma as well as its relationship with angiogenesis in the tumor. IGF2 and IMP3 expression was detected by immunohistochemical staining in the serial sections of the osteosarcoma. The impacts of IGF2 and IMP3 expression patterns on tumor angiogenesis were evaluated by statistics. The IGF2 and IMP3 staining had different expression patterns in different osteosarcoma. Twelve out of the sixty-four cases of conventional osteosarcoma showed nuclear staining patterns, and twenty-nine showed cytoplasmic staining of IGF2 and IMP3 simultaneously. On the other hand, fourteen cases showed nuclear IGF2 staining but cytoplasmic IMP3 expression, and nine cases showed nuclear IMP3 staining and cytoplasmic IGF2 expression. Twenty-eight out of forty-seven cases of parosteal osteosarcoma showed nuclear IGF2 and IMP3 expression, nine showed cytoplasmic IGF2 and IMP3 expression simultaneously. Seven out of forty-seven cases of parosteal osteosarcoma expressed IGF2 with nuclear staining but expressed IMP3 with cytoplasmic staining. Meanwhile, three cases expressed IGF2 with cytoplasmic staining but expressed IMP3 with nuclear staining. Similar to the parosteal osteosarcoma, the periosteal osteosarcoma expressed IGF2 and IMP3 mainly with nuclear staining simultaneously, forty out of fifty-five cases of periosteal osteosarcoma did that. Five out of fifty-five cases expressed IGF2 and IMP3 with cytoplasmic staining at the same time. Four cases showed nuclear IGF2 staining and cytoplasmic IMP3 staining. In the parosteal and periosteal osteosarcoma, there was no significant difference in IGF and IMP3 expression patterns (P = 0.216). However, compared with conventional osteosarcoma, the parosteal and periosteal osteosarcoma showed significant difference in IMP3 and IGF2 expression (P = 0.016, P = 0.023). IGF2 and IMP3 expression patterns were positive correlation in the different osteosarcoma (r = 0.1021, P = 0.032). The Microvessel density (MVD) in osteosarcoma with IGF2 and IMP3 cytoplasmic staining was more than that with nuclear expression of IGF2 and IMP3, and the difference was significant (P = 0.024). Moreover, the conventional osteosarcoma with cytoplasmic IGF and IMP3 showed more MVD than parosteal and periosteal osteosarcoma with cytoplasmic IGF and IMP3, and the difference was significant (P = 0.035). IGF2 and IMP3 had different expression patterns, which might be associated with angiogenesis. However, cytoplasmic and nuclear expression of IGF2 and IMP3 might play different roles in the angiogenesis of osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042095     DOI: 10.1007/s10735-011-9370-2

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  46 in total

1.  The IGFBP-3 mRNA and protein levels are IGF-I-dependent and GH-independent in MG-63 human osteosarcoma cells.

Authors:  R Rosato; K Gerland; H Jammes; N Bataille-Simoneau; B Segovia; L Mercier; A Groyer
Journal:  Mol Cell Endocrinol       Date:  2001-04-25       Impact factor: 4.102

Review 2.  Insulin-like growth factor binding proteins and their role in controlling IGF actions.

Authors:  D R Clemmons
Journal:  Cytokine Growth Factor Rev       Date:  1997-03       Impact factor: 7.638

3.  Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer.

Authors:  S Chava; V Mohan; P J Shetty; M L Manolla; S Vaidya; I A Khan; G L Waseem; P Boddala; Y R Ahuja; Q Hasan
Journal:  Dis Esophagus       Date:  2011-06-10       Impact factor: 3.429

4.  Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype.

Authors:  Y Xie; B Skytting; G Nilsson; B Brodin; O Larsson
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

5.  Effects of androgens on subpopulations of the human osteosarcoma cell line SaOS2.

Authors:  C H Kasperk; K Faehling; I Börcsök; R Ziegler
Journal:  Calcif Tissue Int       Date:  1996-05       Impact factor: 4.333

6.  Insulinlike growth factor action and production in adipocytes and endothelial cells from human adipose tissue.

Authors:  P A Kern; M E Svoboda; R H Eckel; J J Van Wyk
Journal:  Diabetes       Date:  1989-06       Impact factor: 9.461

7.  Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth.

Authors:  C C Kappel; M C Velez-Yanguas; S Hirschfeld; L J Helman
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

8.  Relaxation of imprinted genes in human cancer.

Authors:  S Rainier; L A Johnson; C J Dobry; A J Ping; P E Grundy; A P Feinberg
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

Review 9.  Molecular mechanisms of lymphangiogenesis in health and disease.

Authors:  Kari Alitalo; Peter Carmeliet
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

10.  Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.

Authors:  F K Guerra; A M Eijan; L Puricelli; D F Alonso; E Bal de Kier Joffé; A R Kornblihgtt; E H Charreau; P V Elizalde
Journal:  Int J Cancer       Date:  1996-03-15       Impact factor: 7.396

View more
  7 in total

1.  IGF1 3'UTR functions as a ceRNA in promoting angiogenesis by sponging miR-29 family in osteosarcoma.

Authors:  Shuming Gao; Cai Cheng; Hanwen Chen; Min Li; Kehun Liu; Guangya Wang
Journal:  J Mol Histol       Date:  2016-01-12       Impact factor: 2.611

2.  Expression of IMP3 and IGF2 in giant cell tumor of spine is associated with tumor recurrence and angiogenesis.

Authors:  K Zhang; M Zhou; H Chen; G Wu; K Chen; H Yang
Journal:  Clin Transl Oncol       Date:  2015-03-05       Impact factor: 3.405

Review 3.  Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.

Authors:  Francesco R Evola; Luciano Costarella; Vito Pavone; Giuseppe Caff; Luca Cannavò; Andrea Sessa; Sergio Avondo; Giuseppe Sessa
Journal:  Front Pharmacol       Date:  2017-04-07       Impact factor: 5.810

4.  Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma.

Authors:  Gaoyang Chen; Qingyu Wang; Qiwei Yang; Zhaoyan Li; Zhenwu Du; Ming Ren; Haiyue Zhao; Yang Song; Guizhen Zhang
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

5.  Prognostic value of insulin-like growth factor 2 mRNA-binding protein 3 and vascular endothelial growth factor-A in patients with primary non-small-cell lung cancer.

Authors:  Jiannan Liu; Ying Liu; Wenjing Gong; Xiangshuo Kong; Congcong Wang; Shuhua Wang; Aina Liu
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

6.  Up-regulation of Imp3 confers in vivo tumorigenicity on murine osteosarcoma cells.

Authors:  Arisa Ueki; Takatsune Shimizu; Kenta Masuda; Sayaka I Yamaguchi; Tomoki Ishikawa; Eiji Sugihara; Nobuyuki Onishi; Shinji Kuninaka; Keita Miyoshi; Akihiro Muto; Yoshiaki Toyama; Kouji Banno; Daisuke Aoki; Hideyuki Saya
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

7.  Immunophenotyping of an Unusual Mixed-Type Extraskeletal Osteosarcoma in a Dog.

Authors:  Hyo-Sung Kim; Han-Jun Kim; Hyun-Jeong Hwang; Jong-Hyun Ahn; Sun-Hee Do
Journal:  Vet Sci       Date:  2021-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.